Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
135 hedge funds and large institutions have $780M invested in Amicus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 55 increasing their positions, 34 reducing their positions, and 27 closing their positions.
167% more call options, than puts
Call options by funds: $16.4M | Put options by funds: $6.15M
110.21% more ownership
Funds ownership: 0% → 110.21% (+110%)
62% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 34
4% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 27
1% less funds holding
Funds holding: 136 → 135 (-1)
28% less capital invested
Capital invested by funds: $1.08B → $780M (-$302M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$22M |
| 2 |
Morgan Stanley
New York
|
+$20.8M |
| 3 |
Axa
Paris,
France
|
+$15M |
| 4 |
Jennison Associates
New York
|
+$9.49M |
| 5 |
JP Morgan Chase
New York
|
+$6.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
-$12M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$10M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$9.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.98M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.27M |
FOLD Hedge Fund Activity: Q4 2016 in Review
135 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2016, worth a combined $780M — down 28% from $1.08B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new FOLD positions and 27 closed out — a net gain of 1 holder — while 55 added to existing stakes and 34 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $22M. The largest seller was CQS Cayman, exiting entirely with an estimated $12M sold.
- 135 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2016, down from 136 in Q3 2016.
- Funds reported $780M of Amicus Therapeutics stock for Q4 2016, down 28% quarter-over-quarter.
- 28 funds opened new Amicus Therapeutics positions in Q4 2016 and 27 closed out, a net change of +1 holder.
- The largest Amicus Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $22M added.
- The largest Amicus Therapeutics seller in Q4 2016 was CQS Cayman, an estimated $12M sold.
Based on aggregated 13F filings for Q4 2016.